The stock has demonstrated strong overall performance over the past six months, surging 58.27% from a low near $19.58 in mid-September 2025 to its current level. This rally was punctuated by a significant jump in early December 2025, where the price moved from the low $20s to around $30, where it has since consolidated.

In the short term, the stock has shown resilience, gaining 1.41% over the past month and 3.44% over the past three months, significantly outperforming the broader market (SPY) which declined -5.25% and -4.63% over the same periods, respectively. The 1-month relative strength of 6.66 highlights this outperformance.

The current price of $30.99 is near the top of its 52-week range, sitting just $0.01 below the 52-week high of $31.00 and substantially above the 52-week low of $15.64. This indicates the stock is in a technically strong position, trading at its yearly peak.

Revenue growth remains robust, with Q4 2025 revenue of $314.8 million representing a 20.5% year-over-year increase. However, the company is not yet profitable, reporting a net loss of $79.2 million for the quarter. The net margin improved to -25.2% in Q4 2025 from -33.7% in Q4 2024, indicating a narrowing of losses on a larger revenue base.

The company maintains a strong balance sheet with a healthy current ratio of 3.83 and a debt-to-equity ratio of 0.95. Cash flow from operations was positive at $42.1 million for Q4 2025, and free cash flow for the trailing twelve months is positive at $50.5 million, suggesting improving cash generation despite reported losses.

Operational efficiency metrics show challenges, with a negative Return on Equity (ROE) of -25.3% and a negative Return on Assets (ROA) of -8.1%. The gross margin remains strong at 74.7% in Q4 2025, but operating expenses continue to outpace revenue growth, leading to operating losses.